Clinical Trial Update: Caspofungin Study for Fungal Infections in Adults in Critical Care Settings [Phase 3]

View source ↗

Summary

Phase 3 trial of caspofungin for candidiasis in adults in critical care settings has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis

Drugs mentioned

• Cancidas (caspofungin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Candidiasis | Phase 3 | Status: TERMINATED